Boryung's investment focus is primarily on strengthening its core pharmaceutical business while aggressively expanding into space healthcare, including space medicine, R&D infrastructure, and related ventures. The firm also invests in early-stage digital healthcare companies, prioritizing those that offer new health values over immediate sales indicators.
100% of their portfolio is in Defense & Space. Their most common stage is growth (100% of deals).
Portfolio
1
Fund Size
—
Top Stage
Growth
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 Axiom Space | Growth | $350M | Aug 2023 |
Top Co-Investors
Aljazira Capital1 shared
Last updated: 4 May 2026